1. Lipoprotein (a) level depending on clinical features and level of plasma sphingolipids in patients with early atherosclerosis. (August 2022) Authors: Rogozhina, A.; Alessenko, A.; Minushkina, L.; Gutner, U.; Shupik, M.; Kurochkin, I.; Maloshitskaya, O.; Sokolov, S.; Lebedev, A.; Ivanova, L.; Braznik, V.; Zateyshchikov, D. Journal: Atherosclerosis Issue: Volume 355(2022) Page Start: 61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. The features of sphingolipids' profile in patients with the family history of atherosclerosis. (December 2020) Authors: Rogozhina, A.; Minushkina, L.; Alessenko, A.; Gutner, U.; Shupik, M.; Kurochkin, I.; Maloshitskaya, O.; Sokolov, S.; Zateyshchikov, D. Journal: Atherosclerosis Issue: Volume 315(2020) Page Start: e158 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The features of Sphingolipids' profile in young patients with atherothrombotic stroke. (August 2021) Authors: Rogozhina, A.; Alessenko, A.; Minushkina, L.; Gutner, U.; Shupik, M.; Kurochkin, I.; Lebedev, A.; Sokolov, S.; Zateyshchikov, D. Journal: Atherosclerosis Issue: Volume 331(2021) Page Start: e129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗